Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Forde

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Mbio|January 11, 2022
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary InfectionDavid M P De Oliveira, Brian M Forde, Minh-Duy Phan, et al.
Infection and Immunity|February 11, 2015
Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisitionScott A Beatson, Nouri L Ben Zakour, Makrina Totsika, et al.
Intensive Care Medicine|March 13, 2024
Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsisMing G Chai, Quyen Tu, Menino O Cotta, et al.
The Lancet. Infectious Diseases|October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trialDavid L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Science Translational Medicine|November 19, 2020
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsisDavid M P De Oliveira, Lisa Bohlmann, Trent Conroy, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Mbio|January 11, 2022
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary InfectionDavid M P De Oliveira, Brian M Forde, Minh-Duy Phan, et al.
Infection and Immunity|February 11, 2015
Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisitionScott A Beatson, Nouri L Ben Zakour, Makrina Totsika, et al.
Intensive Care Medicine|March 13, 2024
Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsisMing G Chai, Quyen Tu, Menino O Cotta, et al.
The Lancet. Infectious Diseases|October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trialDavid L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Science Translational Medicine|November 19, 2020
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsisDavid M P De Oliveira, Lisa Bohlmann, Trent Conroy, et al.
Pageof 9